Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Cartherics, ARMI and CCRM Australia announce new agreement for closer cooperation and collaboration
By Christine Filippis / July 5, 2021
Cartherics Pty Ltd and the Australian Regenerative Medicine Institute (ARMI), including commercialisation initiative CCRM Australia, announced agreements for closer cooperation...
Read More
Super-Charging the Immune System to Fight Cancer
By Christine Filippis / June 28, 2021
Innovative immunotherapies for cancer are a step closer to reality thanks to a commercial licence agreement between Australia’s Cartherics Pty....
Read More
CONGRATULATIONS TO CEO ALAN TROUNSON
By Christine Filippis / June 13, 2021
Cartherics is delighted to announce that Alan Trounson has been acknowledged in today’s Queen’s Birthday 2021 Honours and Awards List...
Read More
